Try our Advanced Search for more refined results
Intellectual Property
-
February 20, 2026
Ex-Exec Must Arbitrate Claims In CoStar DQ-Embroiled Spat
A California federal judge sent most of a former Matterport executive's harassment and retaliation suit to arbitration, amid a suit that has prompted CoStar's efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel in separate litigation.
-
February 20, 2026
BioNTech Says Moderna's New COVID Vax Infringes Its IP
BioNTech has launched a new patent infringement suit against Moderna, claiming that the rival's newer COVID-19 vaccine exploits BioNTech's "streamlined, domain-based" vaccine technology, according to a complaint filed in Delaware federal court.
-
February 20, 2026
Squires Sinks 2 PTAB Challenges, Including 1 He Instituted
U.S. Patent and Trademark Office Director John Squires has reversed his own decision and another made by the Patent Trial and Appeal Board to institute a pair of America Invents Act petitions, citing what he called the challengers' inconsistent claim construction.
-
February 20, 2026
Fed. Circ. Backs PTAB Invalidation Of VideoLabs Patent Claims
The Federal Circuit on Friday upheld a decision by the Patent Trial and Review Board that most of the challenged claims in a VideoLabs Collective patent for synchronizing data are invalid, finding VideoLabs had forfeited its argument by raising it for the first time before the circuit.
-
February 20, 2026
Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP
The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different from anything occurring in nature," rendering the therapy patent eligible.
-
February 20, 2026
Fed. Circ. OKs Micron's PTAB Loss In Netlist Patent Challenge
The Federal Circuit on Friday upheld Patent Trial and Appeal Board decisions that Micron Technology Inc. failed to show that claims of a Netlist Inc. computer memory patent are invalid, part of a wide-ranging dispute that includes a nine-figure verdict against Micron on other patents.
-
February 20, 2026
Dinsmore Adds IP Partner In Texas From Fish & Richardson
Dinsmore & Shohl LLP has hired a Fish & Richardson PC intellectual property lawyer who has advanced degrees in mechanical and aerospace engineering and practiced at his previous firm for more than 20 years, the firm announced Wednesday.
-
February 20, 2026
2nd Circ. Backs $286K For Childish Gambino's Attys
The Second Circuit has approved a $286,000 attorney fee award granted to lawyers representing rapper Childish Gambino and his record label in a case from another rapper who alleged part of the hit song "This Is America" was lifted from one of his tracks.
-
February 20, 2026
UK Litigation Roundup: Here's What You Missed In London
The last week in London saw the founders of Getir sue investment fund Mubadala for more than $700 million tied to alleged breaches during the company's restructuring, the Welsh Rugby Union face a claim by Swansea Council over a proposed takeover of Cardiff Rugby, and Euro Car Parks target the Competition and Markets Authority after it was fined by the watchdog. Here, Law360 looks at these and other new claims in the U.K.
-
February 19, 2026
Ex-Google Engineers Took Trade Secrets To Iran, DOJ Says
Three Silicon Valley engineers exploited their employment at Google and other major tech companies in order to steal trade secrets and send the confidential information to personal devices that they then accessed in Iran, the U.S. Department of Justice said Thursday.
-
February 19, 2026
Lab Seeks Rare Essential Patent Injunction In Wi-Fi Case
Citing recent encouragement from federal agencies, a Korean research lab is seeking a rare permanent injunction in a case involving standard essential patents, after a unit of Taiwan's Asus stipulated that its routers infringe the lab's essential Wi-Fi patents.
-
February 19, 2026
Trump's Push For Airport TMs Unprecedented, Experts Say
President Donald Trump's effort to register trademarks for airports that could someday bear his name represents a striking break from how past presidents have gotten their names placed on landmarks, intellectual property attorneys say.
-
February 19, 2026
Justices Urged To Bar Passive Infringement For Skinny Labels
The Federal Circuit cleared the path for branded-drug makers to claim a rival induced infringement of a patent without taking any active steps to do so, Hikma told the U.S. Supreme Court in a case over so-called skinny labels.
-
February 19, 2026
Producers Drop Karol G 'Gatúbela' Suit, Issue Apology
Two music producers who accused star Colombian singer Karol G and Universal Music Group of lifting the beat from their track for her hit song "Gatúbela" told a Florida federal court Wednesday that they are dropping their claims and will publicly apologize.
-
February 19, 2026
Funder Longford Wins Patent Litigation Settlement Dispute
Litigation funder Longford Capital has prevailed in arbitration relating to a dispute with Arigna Technology Ltd. over a settlement that ended certain patent litigation, according to documents filed in Delaware federal court.
-
February 19, 2026
Judge Affirms Literal Infringement In Ravgen's $57M Jury Win
A Texas federal judge has upheld a jury's finding that genetic testing company Natera Inc. committed literal infringement of a patent held by Ravgen Inc., but said Ravgen's expert testimony wasn't enough to support the jury's finding of infringement under the doctrine of equivalents.
-
February 19, 2026
Shkreli Again Tries To Add Wu-Tang Members To Album Fight
"Pharma Bro" Martin Shkreli filed a third-party complaint against two members of hip-hop group Wu-Tang Clan, seeking once again to bring them into litigation brought by a cryptocurrency community that claims Shkreli improperly retained copies of a Wu-Tang album the community had bought the rights to.
-
February 19, 2026
Flavored Air Co. Seeks Ch. 15 Nod In Nevada After Settlement
A Canadian flavored air device company is asking a Nevada bankruptcy judge to recognize the Canadian insolvency proceedings it began earlier this month after falling behind in payments from the settlement of a U.S. trademark infringement suit.
-
February 19, 2026
She Has A Point: Dechert's Kassie Helm
Kassie Helm, co-chair of Dechert LLP's global intellectual property group and head of its IP litigation group, is "unquestionably one of the leading lights of her generation," according to Morrison Foerster LLP partner Daralyn Durie, who praised Helm for her work as opposing counsel in a new series celebrating women litigators.
-
February 19, 2026
Squires Accepts 8 PTAB Cases, Walks Back 7 Merits Referrals
A bulk summary order from U.S. Patent and Trademark Office Director John Squires granted eight petitions for America Invents Act patent challenges while denying 14 others, including seven that he had previously accepted for merits-based review.
-
February 19, 2026
Fed. Circ. OKs Decision Clearing Sony In $500M Patent Case
The Federal Circuit on Thursday upheld a decision that Sony's PlayStation controllers do not infringe a computer input device patent, in a case where Sony said patent owner Genuine Enabling Technology was seeking nearly $500 million in damages.
-
February 19, 2026
Fed. Circ. Won't Revive Corcept's Drug Patent Feud
The Federal Circuit on Thursday declined to revive a case from Corcept Therapeutics Inc. in which it accused Teva Pharmaceuticals USA Inc. of patent infringement over its production of a generic version of the drug Korlym, saying a district judge didn't make a clear error in ruling Corcept hadn't shown any infringement.
-
February 19, 2026
Foley & Lardner Brings On 4 IP, Corporate Attys In Calif.
Foley & Lardner LLP is expanding its California team, announcing Thursday it is adding four partners with technology-related experience — two in San Diego, one in San Francisco and one in Silicon Valley.
-
February 19, 2026
Tech Co. Seeks Morgan Lewis DQ From Smart Glasses Case
A Hong Kong-based tech company has asked a Massachusetts federal judge to kick Morgan Lewis & Bockius LLP off of a case in which it's accusing Meta Platforms and Oakley Inc. of infringing patents with their smart glasses technology.
-
February 19, 2026
TD Garden Owners Say Pot Shops Copying Name
The company that owns Boston sports and entertainment venue TD Garden says a cannabis retail chain is infringing its trademarks by doing business as "The Boston Garden Dispensary," in an infringement lawsuit filed on Wednesday in Massachusetts federal court.
Expert Analysis
-
Series
Teaching Logic Makes Me A Better Lawyer
Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.
-
From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination
With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Upshot Of 'Skinny Label' Case May Go Beyond Pharma
The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.
-
Assessing Factors Behind Biosimilar Uptake And Competition
As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.
-
How 2 Tech Statutes Are Being Applied To Agentic AI
The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.
-
FTC Focus: Testing Joint Enforcement Over Loyalty Programs
The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.
-
NYC Bar Opinion Warns Attys On Use Of AI Recording Tools
Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.
-
Series
The Biz Court Digest: Dispatches From Utah's Newest Court
While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.
-
Checking In On Biologics-Related Patent Review Trends
Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.
-
4 Quick Emotional Resets For Lawyers With Conflict Fatigue
Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.
-
Patent Eligibility Faces Widening Gap Between USPTO, Courts
The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.
-
Series
Playing Tennis Makes Me A Better Lawyer
An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.
-
Expect Major Shifts In Patent And Trademark Policy This Year
New leadership and initiatives promise to bring consequential changes to the U.S. Patent and Trademark Office's practices in 2026, likely favoring patent allowance and issuance, as well as streamlining trademark processes, say attorneys at Knobbe Martens.
-
And Now A Word From The Panel: MDL Year In Review
2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.